R J Pokorski1. 1. Cologne Life Reinsurance Company, Stamford, CT 06905, USA.
Abstract
BACKGROUND: Long-term survival of patients with multiple sclerosis is not well characterized because this disorder is relatively uncommon and subjects must be followed for decades after onset of symptoms. This paper reports comparative mortality experience of the world's largest series on an unselected cohort with multiple sclerosis. RESULTS: Excess mortality varied with age, gender, duration since onset and diagnosis, calender year of onset, and clinical severity. CONCLUSIONS: Compared to the general population in Denmark, patients with multiple sclerosis had less favorable survival experience during long-term follow-up.
BACKGROUND: Long-term survival of patients with multiple sclerosis is not well characterized because this disorder is relatively uncommon and subjects must be followed for decades after onset of symptoms. This paper reports comparative mortality experience of the world's largest series on an unselected cohort with multiple sclerosis. RESULTS: Excess mortality varied with age, gender, duration since onset and diagnosis, calender year of onset, and clinical severity. CONCLUSIONS: Compared to the general population in Denmark, patients with multiple sclerosis had less favorable survival experience during long-term follow-up.
Authors: Moogeh Baharnoori; Virender Bhan; Fraser Clift; Kimberly Thomas; Soukaïna Mouallif; Nicholas Adlard; Philip Cooney; François Blanchette; Barkha P Patel; Daniel Grima Journal: Pharmacoecon Open Date: 2022-09-15
Authors: Ray Gani; Gavin Giovannoni; David Bates; Belinda Kemball; Steve Hughes; John Kerrigan Journal: Pharmacoeconomics Date: 2008 Impact factor: 4.981
Authors: Marita Zimmermann; Elizabeth Brouwer; Jeffrey A Tice; Matt Seidner; Anne M Loos; Shanshan Liu; Richard H Chapman; Varun Kumar; Josh J Carlson Journal: CNS Drugs Date: 2018-12 Impact factor: 5.749
Authors: Timothy Spelman; William L Herring; Thibaut Dort; Yuanhui Zhang; Michael Tempest; Isobel Pearson; Ulrich Freudensprung; Carlos Acosta; Robert Hyde; Eva Havrdova; Dana Horakova; Maria Trojano; Giovanna De Luca; Alessandra Lugaresi; Guillermo Izquierdo; Pierre Grammond; Pierre Duquette; Raed Alroughani; Eugenio Pucci; Franco Granella; Jeannette Lechner-Scott; Patrizia Sola; Diana Ferraro; Francois Grand'Maison; Murat Terzi; Csilla Rozsa; Cavit Boz; Raymond Hupperts; Vincent Van Pesch; Celia Oreja-Guevara; Anneke van der Walt; Vilija G Jokubaitis; Tomas Kalincik; Helmut Butzkueven Journal: Pharmacoeconomics Date: 2021-12-18 Impact factor: 4.981
Authors: Ingrid E H Kremer; Mickael Hiligsmann; Josh Carlson; Marita Zimmermann; Peter J Jongen; Silvia M A A Evers; Svenja Petersohn; Xavier G L V Pouwels; Nick Bansback Journal: Med Decis Making Date: 2020-11 Impact factor: 2.583